+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years - 80Years
All Genders
ID06138236

Study Comparing ESWT and Collagen Hydrolyzed Peptides Treatments for Plantar Fasciitis

Led by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Updated on 2025-12-08

84

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research investigates treatments for patients suffering from Plantar Fasciitis by comparing three different approaches. The study evaluates whether there are differences in outcomes among groups receiving different therapies, focusing on pain and foot function scores. The trial is an early phase 1 interventional study that aims to provide insights into these treatment options. Participants are randomly assigned to one of three groups one receives an infiltration of 2ml of Collagen Hydrolyzed Peptides near the heel spur, the second group undergoes Extracorporeal Shockwave Therapy ESWT, and the third group receives a combination of both treatments. The study assesses the effects of these treatments over time. During the study, participants will be monitored for changes in pain using the Visuoanalogic Scale VAS and foot function using the American Foot and Ankle Scale AFAS at multiple time points between recruitment and up to 60 days. The study observes participants responses to treatment and evaluates outcomes at 15, 30, and 60 days after recruitment to understand the impact of each therapy.

CONDITIONS

Brief Title

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

Research Team

S

Silvana DE GIORGI, PI

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here